NCT06951061

Brief Summary

This research project explores how the source of sperm affects outcomes in assisted reproductive technologies (ART), focusing on children conceived through intracytoplasmic sperm injection (ICSI) with surgically retrieved sperm (SRS). Outcomes will be compared to those from ICSI with ejaculated sperm and conventional IVF. Using national registry data from all IVF and ICSI treatments in Sweden between 2007 and 2023 (Q-IVF), the study applies artificial intelligence (AI) and machine learning (ML) to identify factors influencing success rates. The aim is to improve prediction models and support more personalized fertility treatments. Special emphasis is placed on understanding the potential risks and long-term health outcomes for children conceived using SRS, which may be associated with higher rates of genetic abnormalities. The results may help optimize care strategies for infertile couples.

Trial Health

75
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
200,000

participants targeted

Target at P75+ for all trials

Timeline
12mo left

Started Jan 2007

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress95%
Jan 2007May 2027

Study Start

First participant enrolled

January 1, 2007

Completed
17 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2023

Completed
1.3 years until next milestone

First Submitted

Initial submission to the registry

April 15, 2025

Completed
15 days until next milestone

First Posted

Study publicly available on registry

April 30, 2025

Completed
2.1 years until next milestone

Study Completion

Last participant's last visit for all outcomes

May 30, 2027

Expected
Last Updated

April 30, 2025

Status Verified

April 1, 2025

Enrollment Period

17 years

First QC Date

April 15, 2025

Last Update Submit

April 22, 2025

Conditions

Keywords

perinatal outcomesIVFICSIsurgically retrieved sperm

Outcome Measures

Primary Outcomes (3)

  • Biochemical pregnancy rate

    Positive urinary pregnancy test after fresh or frozen embryo transfer per embryo transfer.

    From enrollment to the end of treatment at 3 weeks

  • Clinical pregnancy rate

    Presence of gestational sac at ultrasound control after fresh or frozen embryo transfer per embryo transfer.

    From enrollment to the end of treatment at 8 weeks.

  • Live birth rate

    Live birth per embryo transfer after fresh and frozen embryo transfer.

    From enrollment to the end of treatment at delivery.

Secondary Outcomes (2)

  • Number of frozen embryos

    From enrollment to the end of treatment at 5 days.

  • Miscarriage rate

    From enrollment to the end of treatment before 22 weeks.

Study Arms (3)

IVF with ejaculated sperm

This group have gone through IVF with ejaculated sperm. Both fresh and frozen cycles are included.

Procedure: IVF/ICSI

ICSI with ejaculated sperm

This group have gone through ICSI with ejaculated sperm. Both fresh and frozen cycles are included.

Procedure: IVF/ICSI

ICSI with surgically retrieved sperm

This group have gone through ICSI with surgically retrieved sperm. Both fresh and frozen cycles are included.

Procedure: IVF/ICSI

Interventions

IVF/ICSIPROCEDURE

In vitro fertilization with or without ICSI with ejaculated and surgically retrieved sperm.

ICSI with ejaculated spermICSI with surgically retrieved spermIVF with ejaculated sperm

Eligibility Criteria

Age18 Years - 45 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)
Sampling MethodNon-Probability Sample
Study Population

In this population-based project, data from the National Quality Registry Q-IVF will be employed to identify a birth cohort comprising all IVF treatments performed in Sweden between January 1, 2007, and December 31, 2023. This time frame aligns with the establishment in 2007 of the National Quality Registry for Assisted Reproduction (Q-IVF). This cohort will be followed until December 31, 2023, resulting in a 16-year period.

You may qualify if:

  • All IVF treatments performed in Sweden during the study period.
  • IVF treatments will be identified from the National register Q-IVF.

You may not qualify if:

  • Children born from multiple pregnancies
  • Children conceived through oocyte and sperm donation

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Department of Clinical Science, Intervention and Technology, Division of Obstetrics and Gynaecology, Karolinska Institute

Stockholm, 17177, Sweden

Location

MeSH Terms

Conditions

Helping Behavior

Condition Hierarchy (Ancestors)

Social BehaviorBehavior

Study Officials

  • Panagiotis Tsiartas, Associate Professor

    Karolinska Institutet

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor

Study Record Dates

First Submitted

April 15, 2025

First Posted

April 30, 2025

Study Start

January 1, 2007

Primary Completion

December 31, 2023

Study Completion (Estimated)

May 30, 2027

Last Updated

April 30, 2025

Record last verified: 2025-04

Data Sharing

IPD Sharing
Will not share

IPD will not be shared because the data will be retrieved from Q-IVF in anonymized form, ensuring that no individual can be identified. As such, there is no access to raw, identifiable data, and sharing is restricted to protect patient confidentiality and comply with data protection regulations.

Locations